Literature DB >> 12946692

The cholinergic basal forebrain system during development and its influence on cognitive processes: important questions and potential answers.

Joanne Berger-Sweeney1.   

Abstract

This review seeks to address, though perhaps not answer fully, four important questions about the cholinergic basal forebrain (BF) system in developing mammals. First, what role does the cholinergic basal forebrain system play in the development of cognitive functions? Second, does the cholinergic BF system play a fundamentally similar role in development vs. adulthood? Third, does sexual dimorphism of the developing cholinergic BF system influence cognition differently in the two sexes? Finally, what role does the developing cholinergic BF system play in developmental disorders such as Down syndrome and Rett syndrome? Examples from the literature, primarily studies in mice and rats, are given in an attempt to answer these important questions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946692     DOI: 10.1016/s0149-7634(03)00070-8

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  28 in total

1.  Volumetric and shape analyses of subcortical structures in United States service members with mild traumatic brain injury.

Authors:  David F Tate; Benjamin S C Wade; Carmen S Velez; Ann Marie Drennon; Jacob Bolzenius; Boris A Gutman; Paul M Thompson; Jeffrey D Lewis; Elisabeth A Wilde; Erin D Bigler; Martha E Shenton; John L Ritter; Gerald E York
Journal:  J Neurol       Date:  2016-07-19       Impact factor: 4.849

Review 2.  Is being plastic fantastic? Mechanisms of altered plasticity after developmental traumatic brain injury.

Authors:  Christopher C Giza; Mayumi L Prins
Journal:  Dev Neurosci       Date:  2006       Impact factor: 2.984

Review 3.  Developmental risk I: depression and the developing brain.

Authors:  John M Weir; Arthurine Zakama; Uma Rao
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-02-17

4.  Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer's disease.

Authors:  Zi-Qiang Shao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  The mouse homeobox gene Gbx2 is required for the development of cholinergic interneurons in the striatum.

Authors:  Li Chen; Mallika Chatterjee; James Y H Li
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

Review 6.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Stephen D Ginsberg; Melissa J Alldred; Barbara J Strupp; Elliott J Mufson
Journal:  Dev Neurobiol       Date:  2019-06-09       Impact factor: 3.964

8.  Acetylcholine receptor and behavioral deficits in mice lacking apolipoprotein E.

Authors:  Jessica A Siegel; Theodore S Benice; Peter Van Meer; Byung S Park; Jacob Raber
Journal:  Neurobiol Aging       Date:  2009-01-28       Impact factor: 4.673

Review 9.  Alzheimer's Disease Therapeutic Approaches.

Authors:  Maria Revi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.

Authors:  Toshio Ariga; Makoto Yanagisawa; Chandramohan Wakade; Susumu Ando; Jerry J Buccafusco; Michael P McDonald; Robert K Yu
Journal:  ASN Neuro       Date:  2010-10-04       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.